Material Agreements

FutureCorp Space Acquisition 1 entered into Sponsor Private Placement Warrants Purchase Agreement with FutureCorp Space Acquisition 1 LLC valued at Private placement warrants purchase agreement with sponsor (effective 2026-06-04).

“A Private Placement Warrants Purchase Agreement, dated June 4, 2026 (the " Sponsor Private Placement Warrants Purchase Agreement "), by and between the Company and FutureCorp Space Acquisition 1 LLC, a Delaware limited liability company (the " Sponsor "), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

FutureCorp Space Acquisition 1 entered into Registration Rights Agreement with certain security holders valued at Registration rights agreement between company and security holders (effective 2026-06-04).

“A Registration Rights Agreement, dated June 4, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

FutureCorp Space Acquisition 1 entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Investment management trust agreement (effective 2026-06-04).

“An Investment Management Trust Agreement, dated June 4, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

FutureCorp Space Acquisition 1 entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Warrant agreement for warrants entitling holder to purchase one Class A Ordinary Share for $11.50 pe (effective 2026-06-04).

“A Warrant Agreement, dated June 4, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

FutureCorp Space Acquisition 1 entered into Underwriting Agreement with Cantor Fitzgerald & Co. valued at Underwriting agreement for 23,000,000 Units at $10.00 per unit, gross proceeds $230,000,000 (effective 2026-06-04).

“Entry into a Material Definitive Agreement. On June 4, 2026, FutureCorp Space Acquisition 1 (the " Company ") consummated its initial public offering (" IPO ") of 23,000,000 units (the " Units "), including 3,000,000 Units issued pursuant to the exercise in full by the underwriters of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.”

Vivakor, Inc. entered into Monarch Transaction Documents with Monarch R&P Management, LLC; CA-2 Materials, Inc. valued at $2,000,000 (effective 2026-06-02).

“On June 2, 2026, Vivakor, Inc. (the “Company”), and its wholly-owned subsidiary, VivaVentures Remediation Processing I, LLC (“VivaVentures”), entered into a series of agreements, including: (i) documents for the formation of Monarch Remediation Processing I, LLC (“ MRP ”), including a Company Agreement, attached hereto as Exhibit 10.1 (the “ MRP Formation Documents ”), (ii) a Site Operations Agreement by and between MRP and CA-2 Materials, Inc. (“ CA-2 Materials ”), attached hereto as Exhibit 10.2 (the “ Site Ops Agreement ”), (iii) a Management Services Agreement by and between MRP and Monarch R&P Management, LLC (“ Monarch R&P ”), attached hereto as Exhibit 10.3 (the “ Management Agreement ”), (iv) a Guaranty Agreement by the Company, attached hereto as Exhibit 10.4 (the “ Guaranty ”) and (v) an Indemnity Agreement, attached hereto as Exhibit 10.5”

Bluejay Diagnostics, Inc. entered into registration rights agreement with certain institutional, accredited investors (effective 2026-06-02).

“On June 2, 2026, Bluejay Diagnostics, Inc. (the “Company”), in connection with a private placement of the Company’s securities, entered into with certain institutional, accredited investors (i) a securities purchase agreement, and (ii) a registration rights agreement (the “private placement”).”

Bluejay Diagnostics, Inc. entered into securities purchase agreement with certain institutional, accredited investors valued at approximately $7.7 million (effective 2026-06-02).

“On June 2, 2026, Bluejay Diagnostics, Inc. (the “Company”), in connection with a private placement of the Company’s securities, entered into with certain institutional, accredited investors (i) a securities purchase agreement, and (ii) a registration rights agreement (the “private placement”).”

BSTR Holdings, Inc. amended Amendment No. 1 to the Loan Agreement with BSTR Holdings (Cayman) valued at $1,100,000 (effective 2026-06-02).

“On June 2, 2026, BSTR and the Lender entered into Amendment No. 1 to the Loan Agreement (the “Amendment”), pursuant to which the principal sum under the Loan Agreement was increased by $1,100,000, from $2,500,000 to $3,600,000.”

BSTR Holdings, Inc. entered into Loan Agreement with BSTR Holdings (Cayman) valued at $2,500,000 (effective 2026-03-15).

“On March 15, 2026, BSTR Newco, LLC, a Delaware limited liability company (“BSTR”), as borrower, entered into a loan agreement (the “Loan Agreement”) with BSTR Holdings (Cayman), a Cayman Island exempted company (the “Lender”), as lender, pursuant to which the Lender agreed to lend BSTR a principal sum of $2,500,000.”

Great Elm Capital Corp. amended Amendment with City National Bank ("CNB") (effective 2026-06-08).

“On June 8, 2026, Great Elm Capital Corp. (the “Company”) entered into an amendment (the “Amendment”) to the Company’s Loan, Guarantee and Security Agreement, dated as of May 5, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified, the “Loan Agreement”), with City National Bank (“CNB”), as lender.”

DAVITA INC. amended Ninth Amendment with JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and swingline lender valued at $500 million (effective 2026-06-08).

“The Ninth Amendment, among other things, provides for an incremental borrowing under the Company’s existing senior secured term loan “B” facility maturing in May 2031 (the “Tranche B-2 Term Facility” and the loans borrowed thereunder, the “Tranche B-2 Term Loans”) in an aggregate principal amount of $500 million”

FS KKR Capital Corp entered into Sixteenth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $900,000,000 aggregate principal amount (effective 2026-06-08).

“On June 8, 2026, FS KKR Capital Corp. (the “Company”) and U.S. Bank Trust Company, National Association (as successor-in-interest to U.S. Bank National Association) (the “Trustee”), entered into a Sixteenth Supplemental Indenture (the “Sixteenth Supplemental Indenture”) to the Indenture, dated July 14, 2014, between the Company and the Trustee (the “Base Indenture”; and together with the Sixteenth Supplemental Indenture, the “Indenture”).”

Spring Valley Acquisition Corp. III entered into Second Amended Business Combination Agreement with General Fusion Inc. and 1573562 B.C. Ltd. (effective 2026-06-03).

“On June 3, 2026, SVIII, NewCo and General Fusion entered into Amendment No. 2 to Business Combination Agreement (as the same may be further amended, supplemented or otherwise modified from time to time, the “ Second Amended Business Combination Agreement ”).”

InterPrivate Investment Partners V, Inc. entered into Administrative Services Agreement with InterPrivate Acquisition Management V LLC valued at Administrative Services Agreement dated June 3, 2026 between the Company and the Sponsor (effective 2026-06-03).

“An Administrative Services Agreement, dated June 3, 2026, between the Company and the Sponsor, a copy of which is filed as Exhibit 10.7 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Private Placement Unit Purchase Agreement with underwriters with Underwriters named in the Underwriting Agreement valued at Private Placement Unit Purchase Agreement dated June 3, 2026 among the Company and the underwriters (effective 2026-06-03).

“A Private Placement Unit Purchase Agreement, dated June 3, 2026, among the Company and the underwriters, a copy of which is filed as Exhibit 10.6 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Private Placement Unit Purchase Agreement with Sponsor with InterPrivate Acquisition Management V LLC valued at Private Placement Unit Purchase Agreement dated June 3, 2026 between the Company and the Sponsor (effective 2026-06-03).

“A Private Placement Unit Purchase Agreement, dated June 3, 2026, between the Company and the Sponsor, a copy of which is filed as Exhibit 10.5 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Registration Rights Agreement with Certain security holders valued at Registration Rights Agreement dated June 3, 2026 among the Company and certain security holders (effective 2026-06-03).

“A Registration Rights Agreement, dated June 3, 2026, among the Company and certain security holders, a copy of which is filed as Exhibit 10.4 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Investment Management Trust Agreement dated June 3, 2026 between the Company and Continental as trus (effective 2026-06-03).

“An Investment Management Trust Agreement, dated June 3, 2026, between the Company and Continental, as trustee, a copy of which is filed as Exhibit 10.3 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Letter Agreement with directors and officers with Directors and officers of the Company valued at Letter Agreement dated June 3, 2026 among the Company and its directors and officers (effective 2026-06-03).

“A Letter Agreement, dated June 3, 2026, among the Company and its directors and officers, a copy of which is filed as Exhibit 10.2 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Letter Agreement with Sponsor with InterPrivate Acquisition Management V LLC valued at Letter Agreement dated June 3, 2026 between the Company and InterPrivate Acquisition Management V LL (effective 2026-06-03).

“A Letter Agreement, dated June 3, 2026, between the Company and InterPrivate Acquisition Management V LLC (the "Sponsor"), a copy of which is filed as Exhibit 10.1 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Warrant Agreement dated June 3, 2026 between the Company and Continental Stock Transfer & Trust Comp (effective 2026-06-03).

“A Warrant Agreement, dated June 3, 2026, between the Company and Continental Stock Transfer & Trust Company ("Continental"), as warrant agent, a copy of which is filed as Exhibit 4.1 to this Report and incorporated herein by reference”

InterPrivate Investment Partners V, Inc. entered into Underwriting Agreement with Cantor Fitzgerald & Co. valued at Underwriting Agreement dated June 3, 2026 between the Company and Cantor Fitzgerald & Co. (effective 2026-06-03).

“An Underwriting Agreement, dated June 3, 2026, between the Company and Cantor Fitzgerald & Co. ("Cantor"), as representative of the underwriters named therein (the "Representative"), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this "Report") and incorporated herein by reference”

CERUS CORP amended Second Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) with MidCap Funding IV Trust, as agent and a lender valued at up to $30.0 million (effective 2026-06-05).

“(ii) a Second Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) (the “Revolving Loan Credit Agreement,” and together with the Term Loan Credit Agreement, the “Credit Agreements”), by and among the Company, the lenders party thereto from time to time and MidCap Funding IV Trust, as agent and a lender, which amended and restated the Company’s existing Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan), dated as of March 31, 2023, as amended”

CERUS CORP amended Second Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) with MidCap Financial Trust, as agent and a lender valued at up to $65.0 million (effective 2026-06-05).

“On June 5, 2026, (the “Closing Date”), Cerus Corporation (the “Company”) entered into (i) a Second Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) (the “Term Loan Credit Agreement”), by and among the Company, the lenders party thereto from time to time (the “Term Loan Lenders”) and MidCap Financial Trust, as agent and a lender, which amended and restated the Company’s existing Amended and Restated Credit, Security and Guaranty Agreement (Term Loan), dated as of March 31, 2023, as amended”

PLEXUS CORP entered into Second Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $500 million (effective 2026-06-05).

“On June 5, 2026, Plexus Corp. (the "Company") entered into a Second Amended and Restated Credit Agreement (the "Second Amended and Restated Credit Agreement") by and among the Company, certain of its subsidiaries from time to time party thereto as borrowers (together with the Company, collectively, the “Borrowers”), the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent”

ATI INC entered into Third Supplemental Indenture with Computershare Trust Company, N.A., as successor trustee to Wells Fargo Bank, National Association, as trustee valued at $450 million (effective 2026-06-08).

“On June 8, 2026, ATI Inc. (the “Company”) completed its offering and sale of $450 million aggregate principal amount of the Company’s unsecured 5.875% Senior Notes due 2033 (the “Notes”).”

HUBBELL INC entered into Underwriting Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc. and HSBC Securities (USA) Inc., as representatives of the several underwriters valued at $500,000,000 aggregate principal amount of its 4.650% Senior Notes due 2031, $700,000,000 aggregate (effective 2026-06-02).

“On June 2, 2026, Hubbell Incorporated ("Hubbell") entered into an underwriting agreement (the "Underwriting Agreement") with J.P. Morgan Securities LLC, BofA Securities, Inc. and HSBC Securities (USA) Inc., as representatives of the several underwriters named in Schedule I thereto (collectively, the "Underwriters"), relating to Hubbell's public offering of $500,000,000 aggregate principal amount of its 4.650% Senior Notes due 2031 (the "2031 Notes"), $700,000,000 aggregate principal amount of its 4.900% Senior Notes due 2033 (the "2033 Notes") and $700,000,000 aggregate principal amount of its 5.150% Senior Notes due 2036 (the "2036 Notes"”

Celcuity Inc. entered into Underwriting Agreement with Jefferies LLC, J.P. Morgan Securities LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC, as representatives of the several underwriters named therein valued at $500,000,000 aggregate principal amount of the Company’s 0.250% Convertible Senior Notes due 2032 (effective 2026-06-03).

“On June 3, 2026, Celcuity Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, J.P. Morgan Securities LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”), agreeing, subject to customary conditions, to issue and sell in a public offering $500,000,000 aggregate principal amount of the Company’s 0.250% Convertible Senior Notes due 2032 (the “Notes”) to the Underwriters (the “Offering”).”

SI-BONE, Inc. amended Third Amendment to Lease with BIXBY SPE FINANCE 11, LLC valued at $43,696 per month (effective 2026-06-05).

“On June 5, 2026, SI-BONE, Inc. (the “ Company ”) and BIXBY SPE FINANCE 11, LLC (“ Landlord ”) entered into the Third Amendment to Lease (the “ Third Lease Amendment ”) to the Office Lease Agreement”

Acushnet Holdings Corp. entered into a equity purchase with Magnus Holdings Co., Ltd. valued at up to an aggregate of $52.5 million (effective 2026-06-08).

“On June 8, 2026 , in connection with its existing $1.25 billion share repurchase authorization, Acushnet Holdings Corp. (the “Company”) entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), pursuant to which the Company will purchase up to an aggregate of $52.5 million of shares of its common stock from Magnus on a share-for-share basis as the Company repurchases shares in the open market or privately negotiated transactions.”

Newton Golf Company, Inc. entered into Purchase Agreement with purchasers valued at up to $3,000,000 (effective 2026-05-28).

“the Company entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell and issue, and the purchasers agreed to purchase, from time to time, in one or more closings, on the terms and conditions contained in the Purchase Agreement, up to $3,000,000 of Convertible Notes and Warrants”

IGC Pharma, Inc. entered into Amendment to Master Loan and Security Agreement with O-Bank Co., Ltd. valued at Facility limit of $12,000,000; facility fee increased from $48,000 to $60,000 (effective 2026-06-05).

“On June 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into an amendment to extend its existing Master Loan and Security Agreement together with the General Banking Facility Letter (collectively, the “Loan Agreement”) with O-Bank Co., Ltd., a banking corporation incorporated under the laws of Taiwan, as lender (the “Lender”). The Loan Agreement continues the facility arrangement previously set forth in the General Banking Facility Letter dated June 24, 2025. The facility provides for a maximum aggregate limit of $12,000,000. The material terms of the facility remain substantially unchanged from the 2025 facility letter, except that the facility fee has increased from $48,000 to $60,000.”

EXOZYMES INC. entered into Underwriting Agreement with MDB Capital valued at approximately $5,330,430 (effective 2026-06-05).

“On June 5, 2026, eXoZymes Inc. (the “Company”) entered into (i) an Underwriting Agreement (the “Underwriting Agreement”), dated as of June 5, 2026, with MDB Capital (“MDB”), as the sole underwriter and book runner, pursuant to which the Company agreed to issue and sell, in a firm commitment underwritten offering (the “Offering”) an aggregate of 592,270 shares of common stock (the “Shares”), $0.000001 par value per share (the “Common Stock”), of the Company and 292,135 warrants to purchase up to an aggregate of 292,135 shares of Common Stock (the “Warrants”).”

AMERICAN BATTERY TECHNOLOGY Co entered into Modification Agreement with United States Department of Energy valued at $115,489,662 (effective 2026-06-02).

“On June 2, 2026, American Battery Technology Company (the “Company”) and the United States Department of Energy (the “DOE”), through its Manufacturing Energy Supply Chain (“MESC”) office, entered into a new agreement to modify (the “Modification Agreement”) the previous Assistance Agreement award number DE-MS0000010 (the “Grant”), for a $115,489,662 project for the design, construction, commissioning, and operation of a commercial scale facility for the manufacturing of battery cathode grade lithium hydroxide.”

Porsche Innovative Lease Owner Trust 2026-1 entered into Underwriting Agreement with BofA Securities, Inc., on its own behalf and as representative of the several underwriters valued at $911,000,000 (effective 2026-06-04).

“On June 4, 2026, Porsche Auto Funding LLC (“PAF”), Porsche Financial Services, Inc. (“PFS”) and BofA Securities, Inc., on its own behalf and as representative of the several underwriters thereunder (collectively, the “Underwriters”), entered into an Underwriting Agreement, for the sale of the following notes to be issued by Porsche Innovative Lease Owner Trust 2026-1 (the “Issuing Entity”): Class A-1, Class A-2a, Class A-2b, Class A-3 and Class A-4 (collectively, the “Notes”) with an aggregate principal balance of $911,000,000.”

Digimarc Corp entered into Sales Agreement with Needham & Company, LLC valued at up to $17,500,000 (effective 2026-06-08).

“On June 8, 2026, Digimarc Corporation (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Needham & Company, LLC (the “Sales Agent”).”

DevvStream Corp. entered into Settlement Agreement and Mutual Release with Helena Global Investment Opportunities 1 Ltd. (effective 2026-06-08).

“On June 8, 2026, DevvStream Corp. (the “Company”) entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with Helena Global Investment Opportunities 1 Ltd. (“Helena”), the holder of the Company’s senior secured Convertible Promissory Note dated July 18, 2025 in the original principal amount of $10,000,000 (the “Note”).”

FAIR ISAAC CORP amended First Amendment with Wells Fargo Bank, National Association valued at $1.5 billion (effective 2026-06-05).

“On June 5, 2026, Fair Isaac Corporation (the “Company”) entered into an amendment (the “First Amendment”) to its Third Amended and Restated Credit Agreement”

Ocean Power Technologies, Inc. entered into Securities Purchase Agreement with those institutional accredited investors identified on the signature page thereto valued at $10.0 million (effective 2026-06-04).

“On June 4, 2026, Ocean Power Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with those institutional accredited investors identified on the signature page thereto (the “Purchasers”)”

CleanCore Solutions, Inc. terminated Amended and Restated Sales Agreement with Maxim Group LLC and Curvature Securities LLC (effective 2026-06-03).

“In connection with the entry into the Sales Agreement, effective as of June 3, 2026, the Company terminated that certain Amended and Restated Sales Agreement, dated August 29, 2025, between the Company, Maxim Group LLC (“Maxim”) and Curvature (the “Prior ATM Agreement”), pursuant to a termination letter entered into by the Company, Maxim and Curvature (the “Termination Letter”).”

CleanCore Solutions, Inc. entered into Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. and Curvature Securities LLC valued at up to an aggregate of $750,000,000 (effective 2026-06-08).

“On June 8, 2026, CleanCore Solutions, Inc. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) and Curvature Securities LLC (“Curvature” and, together with Cantor, the “Agents”), pursuant to which the Company may offer and sell from time to time, through or to the Agents, up to an aggregate of $750,000,000 of the Company’s common stock”

STANDARD BIOTOOLS INC. entered into Agreement and Plan of Merger and Reorganization with Treeline Biosciences, Inc. (effective 2026-06-06).

“Standard BioTools Inc., a Delaware corporation (“Standard BioTools”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Treeline Biosciences, Inc., a Delaware corporation (“Treeline”), and Siri Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Standard BioTools (“Merger Sub”)”

Construction Partners, Inc. amended Third Amended and Restated Credit Agreement with PNC Bank, National Association, as administrative agent and lender, PNC Capital Markets LLC, as joint lead arranger and sole bookrunner, Regions Bank, BofA Securities, Inc., TD Bank, N.A. and City National Bank (effective 2026-06-03).

“the Loan Parties and the Lenders entered into that certain Sixth Amendment to the Third Amended and Restated Credit Agreement (the “Amendment,” and the Term Loan A / Revolver Credit Agreement, as amended by the Amendment, the “Amended Term Loan A / Revolver Credit Agreement”).”

Village Farms International, Inc. entered into Securities Purchase Agreements with certain accredited investors valued at US$15 million (effective 2026-06-05).

“On June 5, 2026, Village Farms International, Inc. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) for the purchase and sale of 7,500,000 of its common shares, no par value per share (“ Common Shares ”), at US$2.00 per share, in a registered direct offering (the “ Offering ”).”

SUNation Energy, Inc. entered into Agreement and Plan of Merger with Suniva, Inc. valued at Merger of Merger Sub into Suniva; Suniva stockholders expected to own 98.2% of combined company (effective 2026-06-05).

“On June 5, 2026, SUNation Energy, Inc., a Delaware corporation (“SUNation”), SUNation Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of SUNation (“Merger Sub”), and Suniva, Inc., a Delaware corporation (“Suniva”), entered into an Agreement and Plan of Merger”

Clean Energy Technologies, Inc. entered into Subordinated Business Loan and Security Agreement with Agile Capital Funding, LLC valued at approximately $260,000 (effective 2026-05-27).

“pursuant to a short-term secured cash advance loan. Under the Company’s loan agreement with Agile, the Subordinated Business Loan and Security Agreement dated May 27, 2026”

SUNation Energy, Inc. entered into Purchase Agreement with certain institutional and accredited investors valued at gross proceeds of $2,700,700 (effective 2026-06-07).

“On June 7, 2026, SUNation Energy, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”) set forth on the signature page thereto for the purchase and sale of an aggregate of 2,390,000 in shares of common stock of the Company, par value $0.05 per share (the “Shares”), for gross proceeds of $2,700,700, which Shares were priced at market at $1.13 per share, based on the closing price of the Company’s Common Stock on the Nasdaq Capital Market on June 5, 2026 (the “Offering”).”

Catheter Precision, Inc. entered into Securities Purchase Agreement with Volato Group, Inc. valued at $1,000,000 (effective 2026-06-07).

“On June 7, 2026, Catheter Precision, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) between Volato Group, Inc. (NYSE American: SOAR), a Delaware corporation (“Volato”), the Company, and other investors party thereto, pursuant to which the Company agreed to purchase 2,941,176 shares of common stock, par value $0.0001 per share, of Volato (“Shares”) at a per share purchase price of $0.34 per share, for an aggregate purchase price of $1,000,000 (the “Subscription Amount”), in a private placement transaction (the “Private Placement”).”

Volato Group, Inc. entered into Securities Purchase Agreement with Catheter Precision, Inc. and certain institutional investors valued at approximately $2.21 million (effective 2026-06-07).

“On June 7, 2026, Volato Group, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Catheter Precision, Inc. (NYSE American: VTAK) and certain institutional investors (collectively, the “Investors”)”